These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8733437)

  • 1. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
    Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
    Yamashita M; Aoki A; Kobayashi H; Wakiya M; Nakatsugawa M
    Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined treatment with prednisone and methotrexate versus prednisone alone over laboratory parameters in giant cell arteritis.
    Perez-Sancristobal I; Alvarez-Hernandez P; Lajas-Petisco C; Fernandez-Gutierrez B
    Reumatol Clin (Engl Ed); 2024 Feb; 20(2):108-112. PubMed ID: 38395494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Kreis L; Dejaco C; Schmidt WA; Németh R; Venhoff N; Schäfer VS
    Trials; 2024 Jan; 25(1):56. PubMed ID: 38225579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell arteritis: a multicenter observational study in Brazil.
    Souza AW; Okamoto KY; Abrantes F; Schau B; Bacchiega AB; Shinjo SK
    Clinics (Sao Paulo); 2013; 68(3):317-22. PubMed ID: 23644850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial.
    Bolhuis TE; Marsman DE; den Broeder AA; den Broeder N; van der Maas A
    Lancet Rheumatol; 2023 Apr; 5(4):e208-e214. PubMed ID: 38251523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm?
    Ricordi C; Pipitone N; Marvisi C; Muratore F; Salvarani C
    Expert Rev Clin Immunol; 2023; 19(10):1195-1203. PubMed ID: 37480289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice.
    Craig G; Knapp K; Salim B; Mohan SV; Michalska M
    Rheumatol Ther; 2021 Mar; 8(1):529-539. PubMed ID: 33638132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Giant cell arteritis. Experience in 32 patients].
    Wurmann P; Hernández C; Zamorano P; Sabugo F; Karsulovic C; Mac-Namara M
    Rev Med Chil; 2022 Jun; 150(6):720-726. PubMed ID: 37906906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica.
    Perricone C; Cafaro G; Fiumicelli E; Bursi R; Bogdanos D; Riccucci I; Gerli R; Bartoloni E
    Clin Exp Med; 2023 Nov; 23(7):3391-3397. PubMed ID: 36566303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the American College of Rheumatology RISE Registry.
    Sattui SE; Xie F; Wan Z; Clinton C; Domsic RT; Curtis JR
    Arthritis Care Res (Hoboken); 2024 Feb; 76(2):259-264. PubMed ID: 37563714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial.
    Saraux A; Le Henaff C; Dernis E; Carvajal-Alegria G; Tison A; Quere B; Petit H; Felten R; Jousse-Joulin S; Guellec D; Marhadour T; Kervarrec P; Cornec D; Querellou S; Nowak E; Souki A; Devauchelle-Pensec V
    Lancet Rheumatol; 2023 Dec; 5(12):e728-e735. PubMed ID: 38251563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.
    Labarca C; Koster MJ; Crowson CS; Makol A; Ytterberg SR; Matteson EL; Warrington KJ
    Rheumatology (Oxford); 2016 Feb; 55(2):347-56. PubMed ID: 26385368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
    Alibaz-Öner F; Kelesoglu B; Balci MA; Yardimci GK; Armağan B; Kiliç L; Karakaş Ö; Erden A; Yasar Bilge S; Kardaş RC; Küçük H; Zengin O; Tasci M; Kocaer SB; Yavuz S; Dogru A; Şahin M; Bayindir O; Sevik G; Ertürk Z; Alpay-Kanitez N; Gogebakan H; Tezcan ME; Oksuz MF; Cefle A; Kucuksahin O; Yazici A; Kasapoglu E; Bes C; Unal AU; Dalkiliç E; Yildirim Çetin G; Aksu K; Keser G; Onen F; Çobankara V; Kisacik B; Onat AM; Öztürk MA; Kaşifoğlu T; Omma A; Karadag O; Ates A; Direskeneli H
    Clin Exp Rheumatol; 2024 Apr; 42(4):816-821. PubMed ID: 37976117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development.
    Iorio L; Padoan R; Bond M; Dejaco C
    Expert Opin Investig Drugs; 2024 Jul; 33(7):671-676. PubMed ID: 38879822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases.
    Font RL; Prabhakaran VC
    Br J Ophthalmol; 2007 Feb; 91(2):204-9. PubMed ID: 16987903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres.
    Quartuccio L; Treppo E; De Martino M; Pillon M; Perniola S; Bruno D; Isola M; Gremese E
    Intern Emerg Med; 2024 Aug; ():. PubMed ID: 39093541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review.
    Hysa E; Bond M; Ehlers L; Camellino D; Falzon L; Dejaco C; Buttgereit F; Aletaha D; Kerschbaumer A
    Rheumatology (Oxford); 2024 Feb; 63(2):285-297. PubMed ID: 37672017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study.
    Unizony S; Matza MA; Jarvie A; O'Dea D; Fernandes AD; Stone JH
    Lancet Rheumatol; 2023 Dec; 5(12):e736-e742. PubMed ID: 38251564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.